This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Karla Therapeutics


Karla is a drug development company with platform potential aiming to revolutionize the treatment of mental disorders harnessing the immune system.We have discovered a novel protein "Imood" secreted by T cells and increased in the blood of psychiatric patients. We have data supporting the therapeutic interest of Imood-targeting in multiple psychiatric conditions including mood disorders.We are developing anti-Imood therapeutic antibodies to treat psychiatric diseases.Company creation: 2022